Baliakas, P., Mattsson, M., Hadzidimitriou, A., Minga, E., Agathangelidis, A., Sutton, L.-A., Scarfo, L., Davis, Z., Yan, X.-J., Plevova, K., Sandberg, Y., Vojdeman, F. J., Tzenou, T., Chu, C. C., Veronese, S., Mansouri, L., Smedby, K. E., Giudicelli, V., Nguyen-Khac, F., Panagiotidis, P., Juliusson, G., Anagnostopoulos, A., Lefranc, M.-P., Trentin, L., Catherwood, M., Montillo, M., Niemann, C. U., Langerak, A. W., Pospisilova, S., Stavroyianni, N., Chiorazzi, N., Oscier, D., Jelinek, D. F., Shanafelt, T., Darzentas, N., Belessi, C., Davi, F., Ghia, P., Rosenquist, R. and Stamatopoulos, K. (2018) “No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy”, Haematologica. Pavia, Italy, 103(4), pp. e158-e161. doi: 10.3324/haematol.2017.182634.